News

News

George Cintra, Senior-Level Neuromodulation Executive, Joins AdvaStim

April 5, 2017

Former CTO of Integer, joins AdvaStim to expand alliance partnerships and commercialization opportunities   BOSTON–(BUSINESS WIRE)–AdvaStim, Inc., www.advastim.com, a leading developer of ASIC-based technology platforms for neuromodulation therapies, announced today that George Cintra has joined the company as Strategic Advisor for Technology and […]

Read More »

Evergreen Medical Technologies Quadruples Size of Cleanroom Manufacturing Space for Implantable Medical Devices

February 22, 2017

Expanded ISO Class 7 and Class 8 Cleanroom Facilities Allow for Single-Source Manufacturing of Active Implantable Medical Devices SAINT PAUL, Minnesota, January 11, 2017:  Evergreen Medical Technologies, a leading developer of Class III active implantable medical devices and systems, today announced the […]

Read More »

It’s Nearly Possible to “Shut off” Parkinson’s with a Flick of a Switch

January 25, 2017

By Benjamin Stecher, Futurism IN BRIEF With the insertion of a metal rod into the brain of participating patients, researchers have used deep brain stimulation to treat Parkinson’s, and the tech is being looked at for use in Alzheimer’s patients. There are also […]

Read More »

Spinal Cord Stimulators Reduce Opioid Use

January 24, 2017

January 24, 2017 By Pat Anson, Editor, Pain News Network Most patients who have a spinal cord stimulator significantly reduce their use of opioid pain medication one year after their implant, according to new industry-funded research. In an analysis of private and Medicare […]

Read More »

Neuromodulation, a weapon in the fight against opioid addiction

December 30, 2016

By Justin Kravcik – December 30, 2016, AddictionNOW Breakthroughs in neuromodulation could create more effective alternatives to prescription painkillers, according to Dr. Konstantin V. Slavin, professor of neurosurgery at the University of Illinois at Chicago. Neuromodulation is a form of non-destructive and minimally […]

Read More »

Medtronic Launches Minimally Invasive Overactive Bladder Treatment

March 31, 2016

Medtronic Launches Minimally Invasive Overactive Bladder Treatment By Suzanne Hodsden MedDeviceOnline Medtronic has launched NURO, a minimally invasive neuromodulation system to treat overactive bladder syndrome (OAB) in patients with urinary urgency, frequency, and urge incontinence.  Research has shown that percutaneous tibial neuromodulation (PTNM) […]

Read More »

Realizing the Promise of Neuromodulation

March 2, 2016

Realizing the Promise of Neuromodulation Posted in Research and Development by MDDI Staff on March 2, 2016 The potential of neuromodulation is not yet being fully realized. Here’s what’s needed to change that. Vaishali Kamat Neuromodulation therapy (also known as neurostimulation in its simpler […]

Read More »

Evergreen Medical Technologies Announces Collaboration with AdvaStim to Develop Next-Generation Neuromodulation Therapy Devices

June 2, 2015

SAINT PAUL, Minnesota, June 2, 2015:  Evergreen Medical Technologies today announced a collaboration agreement to design and develop next-generation, implantable neuromodulation therapy devices using Evergreen’s implantable device capabilities, combined with AdvaStim’s neuromodulation ASICoreTM and ASIControlTM technology platforms. Evergreen Medical Technologies, http://www.evergreenmedtech.com, designs, […]

Read More »
Page 1 of 212